Diabetic retinopathy

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 143-156

  Aiello, Lloyd Paul ^a,c   Gardner, Thomas W ^b   King, George L ^d   Blankenship, George ^d   Cavallerano, Jerry D ^d   Ferris III, Fredrick L ^d   Klein, Ronald ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c JOSLIN DIABETES CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INSULIN;

CRYOTHERAPY; DIABETIC RETINOPATHY; DISEASE COURSE; EARLY DIAGNOSIS; ECHOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; LASER COAGULATION; PATIENT COUNSELING; PATIENT MONITORING; PRACTICE GUIDELINE; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVIEW; VISUAL IMPAIRMENT; VITRECTOMY;

EID: 0031985028     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.143     Document Type: Review

References (85)

1. Ferris FL: How effective are treatments for diabetic retinopathy? JAMA 269:1290-1291, 1993
2. National Diabetes Data Group: Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995 (NIH publ. no. 95-1468)
3. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36:523-534, 1987
4. National Society to Prevent Blindness: Vision Problems in the U.S.: Facts and Figures. ,1980
5. Klein R, Klein BEK, Moss SE: Visual impairment in diabetes. Ophthalmology 91:1-9, 1984
6. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
7. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102:7-16, 1995
8. Javitt JC, Canner JK, Sommer A: Cost effectiveness of current approaches to the control of retinopathy in type 1 diabetics. Ophthalmology 96:255-264, 1989
9. Kahn HA, Hiller R: Blindness caused by diabetic retinopathy Am J Ophthalmol 78:58-67, 1974
10. Palmberg PF: Diabetic retinopathy. Diabetes 26:703-709, 1977
11. Klein R, Klein BEK: Vision disorders in diabetes. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 293-338 (NIH publ. no. 95-1468)
12. Javitt JC, Aiello LP, Bassi LJ, Canner JK: Detecting and treating diabetic retinopathy: financial and visual savings associated with improved implementation of current guidelines. Ophthalmology 98:1565-1574, 1990
13. Javitt JC, Aiello LP, Chiang Y, Ferris FL III, Canner JK, Greenfield S: Preventative eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care 17:909-917, 1994
14. Javitt JC, Aiello LP. Cost effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124:164-169, 1995
15. Dasbach E, Fryback D, Newcomb PA, Klein R, Klien BEK: Cost-effectiveness of strategies for detecting diabetic retinopathy Med Care 29:20-39, 1991
16. Diabetic Retinopathy Study Research Group: Design, methods, and baseline results: DRS Report No. 6. Invest Ophthalmol 21:149-209, 1981
17. Diabetic Retinopathy Study Research Group: Indications for photocoagulation treatment of diabetic retinopathy: DRS report no. 14. Int Ophthalmol Clin 27:239-253, 1987
18. Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: the second report of DRS findings. Ophthalmology 85:82-106, 1978
19. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema: ETDRS report no. 1. Arch Ophthalmol 103:1796-1806, 1985
20. Early Treatment Diabetic Retinopathy Study Research Group: Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: ETDRS report no. 3. Int Ophthalmol Clin 27:254-264, 1987
21. Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy: ETDRS report no. 9. Ophthalmology 98:766-785, 1991
22. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. Ophthalmology 94:747-753, 1987
23. Diabetes Control and Complications Trial Research Group: The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
24. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
25. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
26. The Diabetes Control and Complications Trial Research Group: Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA 276:1409-1415, 1996
27. Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results of a randomized trial: DRVS Report No. 2. Arch Ophthalmol 103:1644-1652, 1985
28. Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: results of a randomized trial: DRVS report no. 3. Ophthalmology 95:1307-1320, 1988
29. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA: Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 37:886-897, 1996
30. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular patterns. IV Diabetic retinopathy Arch Ophthalmol 66:100-112, 1961
31. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification: ETDRS report no. 10. Ophthalmology 98:786-806, 1991
32. Witkin SR, Klein R: Ophthalmologic care for persons with diabetes. JAMA 251:2534-2537, 1984
33. Moss SE, Klein R, Kessler SD, Richie KA: Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 92:62-67, 1985
34. Klein R, Klein BEK, Neider MW, Hubbard LH, Meuer SM, Brothers RJ: Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology 92:485-491, 1985
35. Jacobson DR, Murphy RP, Rosenthal AR: The treatment of angle neovascularization with panretinal photocoagulation. Ophthalmology 86:1270-1275, 1979
36. Murphy RP, Egbert PR: Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 97:700-702, 1979
37. American Optometric Association: Optometric Clinical Practice Guideline: Comprehensive Adult Eye and Vision Examination. St. Louis, MO, American Optometric Association, 1994
38. American Academy of Ophthalmology Quality of Care Committee: Preferred Practice Pattern: Comprehensive Adult Eye Evaluation. San Francisco, CA, American Academy of Ophthalmology, 1992
39. Sussman EJ, Tsiaras WG, Soper KA: Diagnosis of diabetic eye disease. JAMA 247:3231-3234, 1982
40. Gilbert RE, Cooper ME, McNally PG, O'Brien RC, Taft J, Jerums G: Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus. Diabet Med 11:636-645, 1994
41. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Int Med 149:2427-2432, 1989
42. Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D: Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: ETDRS report number 22. Arch Ophthalmol 114:1079-1084, 1996
43. Moss SE, Klein R, Klein BEK: Factors associated with having eye examinations in persons with diabetes. Arch Fam Med 4:529-534, 1995
44. Walker EA, Basch CE, Howard CJ, Zybert PA, Kromholz WN, Shamoon H: Incentives and barriers to retinopathy screening in African-Americans with diabetes. J Diabetes Complications 11:298-306, 1997
45. Klein R, Moss SE, Klein BEK: New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulation. Diabetes Care 10:633-638, 1987
46. American Academy of Ophthalmology: Policy Statement, detection and treatment of diabetic retinopathy, 1988
47. American Optometric Association: Optometric Clinical Practice Guideline: Care of the Patient with Diabetes Mellitus. St. Louis, MO, American Optometric Association, 1994
48. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Retinopathy in young-onset diabetic patients. Diabetes Care 8:311-315, 1985
49. Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR: Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care 9:443-452, 1986
50. Klein BEK, Moss SE, Klein R: Is menarche associated with diabetic retinopathy? Diabetes Care 13:1034-1038, 1990
51. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL: Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 12:686-693, 1989
52. American Academy of Pediatrics, Section on Ophthalmology and Section on Endocrinology: Screening for Retinopathy in Children with Type 1 Diabetes Mellitus (Statement #S94-14). In press
53. Sunness JS: The pregnant woman's eye. Surv Ophthalmol 32:219-238, 1988
54. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 13:34-40, 1990
55. Rodman HM, Singerman LJ, Aiello LM, Merkatz IR: Diabetic retinopathy and its relationship to pregnancy. In The Diabetic Pregnancy: A Perinatal Perspective. Merkatz IR, Adams PAJ, Eds. New York, Grune & Stratton, 1979, p. 73-91
56. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107:237-243, 1989
57. Batchelder T, Barricks M: The Wisconsin Epidemiologic Study of Diabetic Retinopathy (Letter). Arch Ophthalmol 113:702-703, 1995
58. Ferris F: Early photocoagulation in patients with either type 1 or type 2 diabetes. Tr Am Ophth Soc 94:505-537, 1996
59. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Schichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
60. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 113:36-51, 1995
61. The Diabetes Control and Complications Trial Research Group: Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102:647-661, 1995
62. The Diabetes Control and Complications Trial Research Group: The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45:1289-1298, 1996
63. American Academy of Ophthalmology Quality of Care Committee, Retina Panel: Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, CA, American Academy of Ophthalmology, 1993
64. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology 107:237-243, 1989
65. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 107:244-249, 1989
66. Early Treatment Diabetic Retinopathy Study Research Group: Case reports to accompany ETDRS reports 3 and 4. Int Ophthalmol Clin 27:273-333, 1989
67. Bernbaum M, Albert SG, Cohen JD, Drimmer A: Cardiovascular conditioning in individuals with diabetic retinopathy. Diabetes Care 12:740-742, 1989
68. Graham C, Lasko-McCarthey P: Exercise options for people with diabetic complications. Diabetes Educ 16:212-220, 1990
69. Vranic M, Berger M: Exercise and diabetes mellitus. Diabetes 28:147-163, 1979
70. Delio D: Aerobic exercise programs and the management of diabetes. Pract Diabetol 4:12-20, 1985
71. Franz MJ: Exercise and diabetes: fuel metabolism, benefits, risks and guidelines. Clin Diabetes 6:58-70, 1988
72. Horton ES: Role and management of exercise in diabetes mellitus. Diabetes Care 11:201-211, 1988
73. Sharuk GS, Stockman ME, Krolewski AS, Aiello LM, Rand LI: Patient activity and the risk of vitreous hemorrhage in eyes with proliferative diabetic retinopathy (Abstract). Invest Ophthalmol 27 (Suppl.):5, 1986
74. Sharuk GS, Stockman ME, Krolewski AS, Aiello LM, Rand LI: Patient activity and the risk of vitreous hemorrhage in eyes with proliferative diabetic retinopathy (Abstract). Invest Ophthalmol 28 (Suppl.):246, 1987
75. Anderson B Jr: Activity and diabetic vitreous hemorrhages. Ophthalmology 87:173-175, 180, 1980
76. Aiello LM, Cavallerano J, Aiello LP, Bursell SE: Exercise in patients with diabetic complications: retinopathy. In The Health Professional's Guide to Diabetes and Exercise. Ruderman N, Devlin JT, Eds. Alexandria, VA, American Diabetes Association, Clinical Education Series, 1995, p. 143-151
77. Early Treatment Diabetic Retinopathy Study Research Group: Effects of aspirin treatment on diabetic retinopathy: ETDRS report no. 8. Ophthalmology 98:757-765, 1991
78. La Piana FG, Penner R: Anaphylactic reaction to intravenously administered fluorescein. Arch Ophthalmol 79:161-162, 1968
79. Butner RW, McPherson AR: Adverse reactions in intravenous fluorescein angiography. Ann Ophthalmol 15:1084-1086, 1983
80. Wittpenn JR, Rapoza P, Sternberg P Jr, Kuwashima L, Saklad J, Patz A: Respiratory arrest following retrobulbar anesthesia. Ophthalmology 93:867-870, 1986
81. Early Treatment Diabetic Retinopathy Study Research Group: Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report no. 12. Ophthalmology 98:823-833, 1991
82. Stout JP: Psychosocial problems of visually impaired diabetic patients. Semin Ophthalmol 2:62-67, 1987
83. The Diabetes Control and Complications Trial Research Group: Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 18:1468-1478, 1995
84. Klein R, Klein BEK, Moss SE, Davis MD, DeMets GL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871, 1988
85. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. Ophthalmology 113:36-51, 1995